pharmaceuticals

New Delhi, Glenmark Pharmaceuticals on Wednesday said its board has approved the proposal to sell the remaining 7.84 per cent stake in Glenmark Life Sciences through an offer for sale in a deal worth about Rs 778 crore.The Mumbai-based drugmaker said the company's board in its meeting held on...

New Delhi: Shares of Emcure Pharmaceuticals Ltd on Wednesday closed at a premium of over 35 per cent against the issue price of Rs 1,008.The stock started trading at Rs 1,325.05, up 31.45 per cent on both BSE and NSE.During the day, the company's shares rose 37.30 per cent to Rs 1,384 on BSE...

New Delhi: Shares of Emcure Pharmaceuticals Ltd were listed at a premium of over 31 per cent over the issue price of Rs 1,008 on Wednesday.The stock started trading at Rs 1,325.05, up 31.45 per cent on both BSE and NSE.Later, the company's shares rose 37.30 percent to Rs 1,384 on BSE and...

New Delhi: Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic bromfenac ophthalmic solution, indicated for the treatment of postoperative inflammation and pain in patients undergoing cataract surgery.Approval for an...

New Delhi: The initial public offering (IPO) of Bain Capital-backed Emcure Pharmaceuticals Ltd was subscribed 67.87 times on the last day of the offer on Friday amid enthusiastic participation from institutional buyers.According to NSE data, bids were received for 92,99,97,390 shares against...

New Delhi: Bain Capital-backed Emcure Pharmaceuticals Ltd's initial public offering (IPO) received 4.98 times subscription on the second day of the offering on Thursday amid encouraging participation from institutional investors.The initial share sale received bids for 6,81,87,028 shares...

New Delhi: Alembic Pharmaceuticals on Thursday said it has received provisional approval from the US health regulator for generic ivosidenib tablets used in the treatment of certain types of cancer of the bone marrow and bile duct.The company said in a regulatory filing that the provisional...

New Delhi: The initial public offering (IPO) of Bain Capital-backed Emcure Pharmaceuticals Ltd was fully subscribed 1.32 times on the first day of the share sale on Wednesday amid enthusiastic participation from institutional investors.According to NSE data, bids were received for 1,80,25,840...

According to the data, in the first six months of the year, the country exported pharmaceuticals and biotechnology worth 4.5 trillion won (about $3.26 billion), up 55 percent from 2.9 trillion won (about $2.09 billion) in the same period last year. is more. Korea Pharmaceutical and Bio-Pharma...

New Delhi: Bain Capital-backed Emcure Pharmaceuticals is set to launch its initial public offering (IPO) on July 3.According to the red herring prospectus (RHP), the initial share sale will end on July 5 and bidding for anchor investors will open for one day on July 2.The IPO comprises...

New Delhi: Electric two-wheeler startup Ola Electric and Bain Capital-backed Emcure Pharmaceuticals have received approval from Sebi to raise funds through initial public offerings (IPOs), an update with the regulator showed on Thursday. markets.The two companies, which filed their preliminary...

New Delhi: Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic dabigatran etexilate capsules 75 mg and 150 mg, which are used to reduce the risk of stroke and blood clots in adults with a certain medical condition. This is done...

New Delhi, Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for generic icatibant injection indicated to treat acute attacks of hereditary angioedema in adults.Approval by the US Food and Drug Administration (USFDA) of an Abbreviated New...

New Delhi [India], Union Health and Family Welfare Minister Jagat Prakash Nadda directed the Department of Pharmaceuticals to upgrade the quality of all drug and medical device manufacturing plants to world-class standards in the next three years.After assuming charge, Nadda along with...

New Delhi: Torrent Pharmaceuticals on Wednesday said the US health regulator has issued a Form 483 with five observations after inspecting its Gujarat-based manufacturing plant.The US Food and Drug Administration (USFDA) conducted pre-approval inspection (PAI) and GMP inspection at the...

New Delhi: Acme Drugs and Pharmaceuticals on Monday said it has launched a combination drug for gastrointestinal tract disorders.The contract development and manufacturing organization has launched Rabeprazole and Levosulpiride SR capsules after receiving approval from the Drug Controller...

MUMBAI: Diversified Torrent Group on Friday crossed US$20 billion (Rs 1.68 lakh crore) in market capitalisation, almost doubling its market value due to strong growth in businesses spanning from pharma to energy.Torrent Group's m-cap as on 6 June 2023 was US$10.8 billion (Rs 90,230 crore).On...

New Delhi, Torrent Pharmaceuticals on Wednesday said it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize vonoprazan in India.Vonoprozan is a novel potassium-competitive acid inhibitor (P-CAB), used for the treatment of the acid-related disorders...

New Delhi, Torrent Pharmaceuticals on Wednesday said it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize vonoprazan in India.Vonoprozan is a novel potassium-competitive acid inhibitor (P-CAB), used for the treatment of the acid-related disorders...

New Delhi: Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic drug used to treat certain types of heart failure.Alembic said in a regulatory filing that the company has received final approval from the US Food and Drug...